olprinone has been researched along with Endotoxemia in 2 studies
olprinone: RN refers to HCl; structure given in first source
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was performed in order to assess the effects of olprinone, a phosphodiesterase III inhibitor, on hepatic oxygen delivery (DO2H), oxygen consumption (VO2H), and mitochondrial oxidation in the liver of a porcine endotoxemia model." | 7.73 | Effects of olprinone on hepatosplanchnic circulation and mitochondrial oxidation in a porcine model of endotoxemia. ( Hashiguchi, T; Isowaki, S; Kakihana, Y; Kaminosono, T; Kanmura, Y; Kawamae, H; Kuniyoshi, T; Nagata, E; Okayama, N; Tahara, M; Tobo, K, 2005) |
| " The administration of olprinone (phosphodiesterase III inhibitor) improves the liver blood flow circulation in a porcine model of endotoxemia." | 7.71 | The effects of olprinone (a phosphodiesterase III inhibitor) on hepatic vascular bed in a porcine model of endotoxemia. ( Isowaki, S; Kakihana, Y; Kanmura, Y; Nagata, E; Tobo, K, 2001) |
| "This study was performed in order to assess the effects of olprinone, a phosphodiesterase III inhibitor, on hepatic oxygen delivery (DO2H), oxygen consumption (VO2H), and mitochondrial oxidation in the liver of a porcine endotoxemia model." | 3.73 | Effects of olprinone on hepatosplanchnic circulation and mitochondrial oxidation in a porcine model of endotoxemia. ( Hashiguchi, T; Isowaki, S; Kakihana, Y; Kaminosono, T; Kanmura, Y; Kawamae, H; Kuniyoshi, T; Nagata, E; Okayama, N; Tahara, M; Tobo, K, 2005) |
| " The administration of olprinone (phosphodiesterase III inhibitor) improves the liver blood flow circulation in a porcine model of endotoxemia." | 3.71 | The effects of olprinone (a phosphodiesterase III inhibitor) on hepatic vascular bed in a porcine model of endotoxemia. ( Isowaki, S; Kakihana, Y; Kanmura, Y; Nagata, E; Tobo, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuniyoshi, T | 1 |
| Kakihana, Y | 2 |
| Isowaki, S | 2 |
| Nagata, E | 2 |
| Tobo, K | 2 |
| Kaminosono, T | 1 |
| Hashiguchi, T | 1 |
| Tahara, M | 1 |
| Kawamae, H | 1 |
| Okayama, N | 1 |
| Kanmura, Y | 2 |
2 other studies available for olprinone and Endotoxemia
| Article | Year |
|---|---|
Effects of olprinone on hepatosplanchnic circulation and mitochondrial oxidation in a porcine model of endotoxemia.
Topics: Animals; Disease Models, Animal; Electron Transport Complex IV; Endotoxemia; Endotoxins; Hemoglobins | 2005 |
The effects of olprinone (a phosphodiesterase III inhibitor) on hepatic vascular bed in a porcine model of endotoxemia.
Topics: Animals; Disease Models, Animal; Endotoxemia; Imidazoles; Liver Circulation; Oxygen; Phosphodiestera | 2001 |